New nomenclature for fatty liver disease
2024; Danish Medical Association; Linguagem: Inglês
10.61409/v12230778
ISSN1603-6824
AutoresCamilla Dalby Hansen, Katrine Prier Lindvig, Henning Grønbæk, Lise Lotte Gluud, Maja Thiele, Aleksander Krag,
Tópico(s)Diet, Metabolism, and Disease
ResumoThis review investigates that, in 2023, fatty liver disease underwent a name change to “steatotic liver disease” (SLD). SLD now includes metabolic dysfunction-associated steatotic liver disease (MASLD), alcohol-related liver disease (ALD), and metabolic and alcohol-related liver disease (MetALD). The renaming aims to better incorporate alcohol intake and metabolic risk factors into disease classification and to diminish the stigma associated with the previous nomenclature. Early identification of the patient’s aetiology is important for the prognosis which can be improved by interventions against the causative risk factors.
Referência(s)